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Abstract
Background The study of the geographical distribution of
disease has expanded greatly with GIS technology and its
application to increasingly available public health data.
The emergence of this technology has increased the chal-
lenges for public health practitioners to provide meaningful
interpretations for county-based state cancer maps.
Methods One of these challenges—spurious inferences
about the signiﬁcance of differences between county and
overall state cancer rates—can be addressed through a non-
parametric statistical method. The Wilcoxon’s signed rank
test (WSRT) has a practical application for determining the
signiﬁcance of county cancerrates compared tothe statewide
rate. This extension of the WSRT, developed by John Tukey,
forms the basis for constructing a single conﬁdence interval
for all differences in county and state directly age-adjusted
cancer rates. Empirical evaluation of this WSRT application
was conducted using Minnesota cancer incidence data.
Results The WSRT procedure reduced the impact of
statistical artifacts that are frequently encountered with
standard normal signiﬁcance testing of the difference
between directly age-adjusted county and the overall state
cancer rates.
Conclusion Although further assessment of its perfor-
mance is required, the WSRT procedure appears to be a
useful complement for mapping directly age-adjusted state
cancer rates by county.
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Introduction
The county as a geographic basis for describing state
cancer incidence
For many years, investigators have evaluated geographic
patterns of cancer occurrence by county to generate etiologic
hypotheses [1–3]. For example, observations of higher lung
cancerandmesotheliomaratesintheshipbuildingareasonthe
eastern seaboard of the United States contributed to an
understanding of the carcinogenic potential of asbestos [4].
Cancer rates in counties with nuclear power plants have been
comparedto similar counties without plants toaddress public
concerns [5]. In Minnesota, the observation of a large and
persistent increase in mesothelioma incidence in the north-
eastern region of the state led to the discovery that taconite
miners were at high risk of the disease [6].
Evaluation of cancer rates by county for etiologic
hypothesis development and testing has limitations [7, 8].
These evaluations are ecologic analyses [9] that are based
on aggregated exposure and demographic data for larger
areas and frequently diverse populations. The emergence of
the analytic capabilities of geographic information systems
(GIS) has led many investigators to study geographical
variations of cancer occurrence for geographic units
smaller than the county [10].
Displaying cancer incidence by county remains a valu-
able tool for describing the occurrence of cancer to the
general public. County cancer rates are also important to
community health assessments and allocation of public
health resources [11]. County administrators and local
public health ofﬁcials are keenly interested in knowing
how their county’s cancer rates compare to the state and
whether any differences are signiﬁcant. A wide range of
audiences identify with county-based cancer rates, and for
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county is often the geographic unit of choice [12, 13].
Challenges of disease mapping
In 1976, the eminent statistician Tukey [14] described the
future challenge for disease mapping as the requirement to
inform and not mislead through the creation of what he
called a ‘‘propaganda device.’’ Today, the development of
GIS has expanded the capacity to map large databases of
health outcomes at a high level of spatial speciﬁcity. These
data can now be linked to other environmental information
and population risk factors [15]. The challenges articulated
by Tukey 35 years ago continue to apply to the spatial
measurements and statistics of GIS analysis today [16].
The appropriate methodology to ensure that maps of
health statistics inform and not mislead is the subject of
much discussion and research [17, 18]. Statistical inaccu-
racies often arise from mapping differences between
county and the overall state directly age-adjusted cancer
rates. Inaccurate speciﬁcation of signiﬁcance when multi-
ple counties and the state are compared, and inaccuracy of
estimates used in calculating standard normal tests of sig-
niﬁcance can lead to spurious inferences about the number
of statistically signiﬁcant differences between county and
overall state cancer rates.
Multiple comparisons
Developing a map representing differences between county
rates and the overall state rate involves many different
geographic comparisons (eighty-seven in Minnesota). A
table of eighty-seven differences provides the opportunity
for simultaneously evaluating eighty-seven separate
hypotheses. If there is a 5% chance that each of the indi-
vidual conﬁdence intervals does not contain the true dif-
ference in rates, the probability that all eighty-seven
conﬁdence intervals contain the true difference is consid-
erably less than 95%. The distinction between a single
statistical test of hypothesis that the county rate and state
rate are not different and a test of all differences is referred
to as the multiple inference or multiple comparison prob-
lem [19].
When the number of comparisons is large, the potential
for error in the inferences increases. In Minnesota, the
probability that at least one of the differences will be found
to be statistically signiﬁcant (at the 0.05 level) is 1 -
(0.95)
87 = 0.99 [20]. Comparing many county rates creates
a markedly greater probability of generating positive
ﬁndings due to chance than does the stated 0.05 level.
The problem of multiple comparisons applies to cancer
mapping as well. The graphical representation is based on
the tabular values of differences between county and
overall state rates. If the comparisons are mapped based on
a single comparison test of statistical signiﬁcance, then
eighty-seven different comparisons are implied but not
distinctly stated by the map itself. The high likelihood that
one or more of the ‘‘statistically’’ different county rates is
due to chance is integrated into the global representation of
the map.
Errors in estimation
The standard normal statistical test for the difference
between two directly age-standardized cancer rates can be
approximated by a formula that assumes that the covari-
ance of the two rates is zero, that is, the two rates are
independent. The estimate for the variance of the differ-
ence between two directly age-adjusted cancer rates is the
sum of each cancer rate’s variance estimate [21]. If the
independence assumption is violated, a more accurate
representation for the variance of the difference in rates is
the sum of the two variances minus twice their covariance
[22]. As the number of tests of signiﬁcance increases, the
possibility of major violations of the underlying assump-
tion of independence also increases.
The assumption of independence is frequently violated
when one of the rates is for a populous county. Cancer rates
for populous counties are often positively correlated with
the overall state rate since the county has a relatively large
impact on the state rate. Assuming that the covariance is
zero, when it is numerically positive, creates a loss of
statistical power (the conﬁdence intervals are spuriously
large). Removing the county before calculating the overall
state rate would mitigate this dependence to some degree
but would result in a different overall state rate for each
county—an undesirable outcome.
A negative covariance can occur for sparsely populated
rural counties. For example, if populous urban counties had
a higher smoking prevalence (compared to some non-urban
counties) as in Minnesota, then the overall state rate for
smoking-related cancers would tend to be higher and the
cancer rates for counties with lower smoking prevalence
would be relatively lower for these cancers. The result of
assuming that the numerically negative covariance is zero
would be an over speciﬁcation of signiﬁcance (spuriously
narrow conﬁdence intervals).
This paper describes a method to evaluate the signiﬁ-
cance of county cancer incidence rates compared to the
overall state rate that is more resistant to the artifacts
created by these statistical inaccuracies than are the fre-
quently used standard normal tests of signiﬁcance. This
method is complementary to the graphical presentation of
county cancer rates employed by states and larger gov-
ernmental units when speciﬁcation of signiﬁcance is also
desired.
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Tukey’s modiﬁcation of the Wilcoxon’s signed rank test
(WSRT) is a nonparametric procedure. A detailed
description of the theoretical basis of the large sample
approximation for the distribution-free conﬁdence interval
employed here is given in the text [23]. This text is still
considered by many statisticians as a standard for applied
nonparametric statistics [24].
The WSRT procedure as applied here uses a measure of
the average of all possible boundaries of the m (number of
counties) 95% standard normal conﬁdence intervals. Six
steps based on Tukey’s extension of the WSRT procedure
are proposed to calculate a joint conﬁdence interval for all
differences between directly age-adjusted county cancer
rates and the overall state rate.
1. Form m 95% standard normal conﬁdence intervals
using the Keyﬁtz formula [25] for the standard errors
of the directly age–adjusted rates creating the m lower
and upper conﬁdence limits: (CILi,C I U i); i = 1, m.
Let diffi = c ratei - s rate; i = 1, m (c is the county, s
is the state), and sei = standard error of c ratei,i s
calculated as follows, for a given sex and 18 age
groups, se2
i ¼
P18
j¼1 Nj=P2
j
  
ðWjÞ
2; where Nj is the
number of speciﬁc cancers (e.g., lung) in the ith
county, Pj is the population of the jth age group for the
given sex of the ith county, Wj is the US 2000 standard
population weight for the jth age group, se = standard
error of s rate, (calculated with total state data for Nj
and Pj) and, the standard error of the difference
between the county and state rate, seðdiffiÞ¼
se2
j þ se2
   1=2
, with the 95% standard normal conﬁ-
dence interval = diffi ± 1.96 se(diffi) = (CILi, CIUi)
[21].
2. Form the M ¼
mðmþ1Þ
2 averages of the lower and upper
bounds of the m 95% standard normal conﬁdence
intervals [23]. These are called Walsh (W) averages.
For m = 87 (Minnesota), M ¼
mðmþ1Þ
2 ¼ 3;828;
Wk
L ¼ð CILi þ CILjÞ=2;
Wk
U ¼ð CIUi þ CIUjÞ=2; i j; k ¼ 1;2;...;3;828:
3. Rank (sort) both lower and upper sets of Walsh
averages, so that:
W1
L  W2
L      WM
L ;
W1
U  W2
U      WM
U :
4. The 1 - a conﬁdence interval for the lower limit is
WCa
L ;W
ðMþ1 CaÞ
L
  
, and the 1 - a interval for the
upper limit is WCa
U ;W
ðMþ1 CaÞ
U
  
; where Ca ¼
mðmþ1Þ
4   Zða=2Þ
mðmþ1Þð2mþ1Þ
24
hi 1=2
:
(Ca rounded to the nearest integer determines the two
elements of the ordered arrays of Walsh averages that
serve as end points of the joint conﬁdence interval, a is
usually 0.05).
5. For i = 1, m use WCa
L ; W
ðMþ1 CaÞ
U
  
as the joint
conﬁdence interval for all the diffi.
6a. If the (CILi, CIUi) does not contain zero, the
signiﬁcance of the diffi is then determined by the
joint conﬁdence interval derived in 5).
6b. If the diffi lies outside the joint conﬁdence interval, it
is concluded that the county rate is different than the
state rate. For m = 87 counties and Z(a/2) = 1.96,
Ca = 1,451, M ? 1 - Ca = 2,378; and 5) becomes
W1451
L ; W2378
U
  
.
A detailed example of the calculations required for the
application of this nonparametric procedure described by
steps (1)–(6b) is given in ‘‘Appendix 1.’’ This algorithm
producesajoint(single)conﬁdenceintervalforalldifferences
betweenthecountyandstaterates,foragivensexandcancer.
The 95% standard normal conﬁdence intervals, (CILi,C I U i),
are speciﬁc to each county for the null hypothesis H0:d i f f i
(county ratei—state rate; for a given sex and cancer) = 0.
The purpose of the analysis is to identify differences in
cancer rates that lie outside (CILi, CIUi) whose statistical
signiﬁcance is less likely due to multiple comparisons and
possible lack of the independence of the two rates.
Therefore, the application of step 6b) requires that step 6a)
ﬁrst be satisﬁed. Any difference where zero lies inside the
standard normal 95% conﬁdence interval is judged as
nonsigniﬁcant and is not compared to the joint interval
WCa
L ; W
ðMþ1 CaÞ
U
  
.
The number of years, age groups, number, and types of
cancer were varied, and the performance of the WSRT
procedure was evaluated for 300 separate analyses of dif-
ferent combinations of these variables for Minnesota and
its eighty-seven counties. The performance was evaluated
by the empirical method of comparing inferences derived
from the WSRT procedure to those derived from the 95 and
99% standard normal tests and the 90% Bonferroni test of
signiﬁcance (the Bonferroni test is based on the standard
normal test of signiﬁcance with the signiﬁcance level
adjusted to reduce the number of false positives) [26].
Speciﬁcity of the WSRT procedure was assessed by
determining if an elevated number of signiﬁcant differ-
ences were reduced. Sensitivity was evaluated by deter-
mining which of the discrepant inferences derived from the
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detailed examination of additional data.
The data used for these comparisons were from the Min-
nesota Cancer Surveillance System [27]. The MCSS is a
population-based statewide cancer registry that has been in
operation since 1988. Several examples of these analyses are
providedtoillustratetheperformanceoftheWSRTprocedure
tothisapplication.ResultsoftheWSRTprocedurearelabeled
intheparlancesuggestedbyTukeyas,‘‘unusuallylow,’’‘‘not
unusual,’’ and ‘‘unusually high’’ [14].
Results
Figure 1 is a map of the 95% standard normal signiﬁcance
tests of the difference between the directly age-standardized,
county-speciﬁc female lung cancer incidence rates for
1988–2007andthecorrespondingoverallMinnesotarate[21,
25]. The number of counties with signiﬁcantly low lung
cancer rates is the dominant feature of this map.
Figure 2 contains the WSRT procedure alternative to the
map provided by Fig. 1. The difference between Figs. 1
and 2 is the method used to determine which of the county
rates were different than the overall state rate. The WSRT
procedure determination of signiﬁcance generated a map
(Fig. 2) in which the number of counties with signiﬁcantly
different rates was substantially reduced.
The National Cancer Institute’s SEER*Stat software
provides additional parametric methods, based on rate
ratios, for determining statistical signiﬁcance of county
age-adjusted cancer rates compared to the overall state rate
[28]. The results of the SEER*Stat determinations of
significantly low
non significant
significantly high
Fig. 1 Age-adjusted female lung cancer incidence compared to overall state female age-adjusted rate by county (1988–2007). Signiﬁcance
determined by 95% standard normal conﬁdence interval for difference in the two rates
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this report, for the data depicted in Figs. 1 and 2 are given
in Table 1. Results of the standard normal tests and the
SEER*Stat rate ratio tests of signiﬁcance produced similar
results. For relatively large counts, this similarity is
expected [29, 30] and these methods would result in a map
similar to Fig. 1.
Table 2 contains a summary for all MCSS data, 32
cancer types (‘‘Appendix 2’’), 20 years (1988–2007), and
all age groups that represented 429,794 cancers. Biologi-
cally, inconsistent cancer and gender combinations were
excluded. There were ﬁve of these. The number of total
comparisons for the 1988–2007 aggregated data was 5,133
(27 9 87 9 2 ? 5 9 87).
The 95% standard normal test resulted in 882 (17.2% of
5,133) differences between county and overall state rates
being classiﬁed as signiﬁcantly lower than zero and 170
(3.3%) as signiﬁcantly larger than zero. In other words,
there were 882 county rates signiﬁcantly lower than the
overall state rate and 170 signiﬁcantly higher. This large
proportion of signiﬁcantly low rates is a measure of the
spuriously signiﬁcant differences that can result when
comparing many county rates to the overall state rate and
when the independence of the county rates and the overall
state rate are an issue. Another indication of this artifact is
provided by the 170 comparisons that were signiﬁcantly
high. Only 128 (2.5%) of the rates were expected to be
signiﬁcantly high.
Results of the 99% standard normal test demonstrated
the expected overall reduced numbers of statistically sig-
niﬁcant results. However, there was still evidence of spu-
riously signiﬁcant differences, most notably for low rates
unusually low
not unusual
unusually high
Fig. 2 Age-adjusted female lung cancer incidence compared to overall state female age-adjusted rate by county (1988–2007). Signiﬁcance
determined by Wilcoxon’s signed rank test (WSRT) procedure described in text
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reduce the number of false positives, was more conserva-
tive, in that, it severely reduced the number of signiﬁcantly
elevated rates to 0.7%. The Bonferroni test was not as
effective in mitigating the impact of low rates; 488 (9.5%)
remained signiﬁcant.
Results from the WSRT procedure provided a different
perspective. Only 2.5% of the county rates were signiﬁ-
cantly low and 1.5% were high. The number of signiﬁ-
cantly low rates was reduced, and the sensitivity for
detecting elevated county rates did not appear to be greatly
impaired. The 1.5% of the rates considered signiﬁcantly
high exceeded that estimate for both the 99% standard
normal and the 90% Bonferroni tests. The only result that
was larger (3.3%) was for the 95% standard normal test and
that number was likely skewed too large by the multiple
comparisons (5,133) that were made. For these data, the
WSRT procedure greatly reduced the number of apparently
spurious results generated by the three standard normal
tests of signiﬁcance.
Figures 3 and 4 represent the comparison of the female
age-adjusted all-cancer incidence rate to the state rate for
the years 1988–2007 by county. Determination of signiﬁ-
cance in Fig. 3 was by the 95% standard normal test and in
Fig. 4 by the WSRT procedure. The difference in impres-
sions of signiﬁcance created by eliminating statistical
artifact afforded by the WSRT procedure compared to the
standard normal tests is seen again in these two ﬁgures.
Throughout this evaluation, reduction in the number of
counties with cancer rates statistically different than the
overall state rate was a prominent feature of the WSRT
procedure.
Large numbers
Precision of the estimates for age-adjusted rates mapped in
Figs. 3 and 4 was relatively high. These rates included all
female cancers, for all years, which incorporated the largest
numbers available. The problem of estimating rates from a
small number of occurrences, or small populations, is well
documented [31]. Large numbers represent another prob-
lem [32] that frequently results in speciﬁcation of statistical
signiﬁcance for very small differences in rates.
Figures 5 and 6 represent comparisons of the incidence
of a common male cancer (colon/rectum) to the overall
state rate for the years 1988–2007 by county. Results of the
95% standard normal signiﬁcance determinations yielded 6
(6.9%) counties with low rates and 14 (16.1%) with sig-
niﬁcantly higher age-adjusted rates than the overall Min-
nesota rate. The WSRT analysis yielded 2 (2.3%) and 5
(5.7%) of the counties with unusually lower and higher
rates, respectively, than the cancer rate for the state as a
whole. For this example, the WSRT procedure reduced the
number of signiﬁcant outcomes by nearly two-thirds. The
WSRT procedure consistently reduced the number of sig-
niﬁcant inferences for differences between county and
overall state rates when the comparisons involved rela-
tively common cancers (large numbers).
Small numbers
For less common cancers, there were many zero occur-
rences in a county during the time period (1988–2007). Of
the 882 (Table 2) county rates signiﬁcantly lower than the
corresponding state rate, 358 of these were for zero rates.
Table 1 Comparison of signiﬁcance assessments of age-adjusted female lung cancer incidence compared to overall state female age-adjusted
rate by county (Minnesota, 1988–2007)
Signiﬁcantly low Signiﬁcantly high Nonsigniﬁcant
SN95 SN99 B90 T95 F95 WSRT SN95 SN99 B90 T95 F95 WSRT SN95 SN99 B90 T95 F95 WSRT
Summary counts for the 87 counties
40 25 18 35 34 8 10 7 4 10 10 8 37 55 65 42 43 71
Standard Normal 95% CI (SN95), Standard Normal 99% CI (SN99), Bonferroni 90% CI (B90), Tiwari 95% CI (T95) [30], Fay 95% CI (F95)
[29], and WSRT 95% CI (WSRT) [Wilcoxon’s signed rank test—see text]
Table 2 Number (%) of statistically signiﬁcant county rates for four tests of signiﬁcance—32 cancers, 87 counties, and 2 sexes
Standard normal (95%) Standard normal (99%) Bonferroni (90%) WSRT
a (95%)
Low High Low High Low High Low High
882 (17.2) 170 (3.3) 616 (12.0) 69 (1.3) 488 (9.5) 34 (0.7) 130 (2.5) 76 (1.5)
Total comparisons = 5,133. Biologically inconsistent cancer and gender combinations excluded
MCSS 1988–2007 [All ages (n = 429,794 total cancers)]
a Wilcoxon’s signed rank test—see text
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tions from the overall state rate by the WSRT procedure;
only 19 of 130 low rates were derived from zero county
rates. The relative insensitivity to the impact of zero
occurrences (and very small cell size in general) is a known
behavior of the WSRT procedure [23] that is important to
reducing small number artifact that complicates compari-
son of individual county cancer rates to the overall state
rate.
Table 3 contains similar data as Table 2 except the
years included were 2003–2007. The total number of
cancers was reduced from 429,794 to 121,908 and the
number of zero occurrences in the counties increased. The
effect of this increase was to sharply elevate the number of
signiﬁcantly low rates derived from the standard normal
tests. The number of signiﬁcantly low rates identiﬁed by
the WSRT procedure decreased from 130 (2.5%) to 82
(1.6%). This decrease was a desirable outcome. As the
precision of the estimates decreased (with less nonzero
data), the number of occurrences considered signiﬁcantly
low should also decrease. As seen with the more numerous
data from Table 2, the sensitivity of the WSRT procedure
for elevated rates, determined by the percentage of com-
parisons that were signiﬁcantly high, was between that of
the 95% standard normal test and the other two methods.
Table 4 contains data for childhood (ages 0–14 years)
cancers for all years combined (1988–2007). This analysis
was based on a substantially smaller number of cancers
(3,188) than Table 3. Since all 32 cancer types were ana-
lyzed separately, there were a very large number of zero
significantly low
non significant
significantly high
Fig. 3 Age-adjusted female all-cancer incidence compared to overall state female age-adjusted rate by county (1988–2007). Signiﬁcance
determined by 95% standard normal conﬁdence interval for difference in the two rates
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extreme situation for data populated with zero or a very
small number of occurrences. The performance of the
WSRT procedure in reducing the number of spuriously low
rates was even more evident in this extreme situation.
Example: bone cancer
For the period 2003–2007, there were 168 bone cancers
diagnosed in males and 113 in females of all ages in
Minnesota. The overall state male standard normal 95%
conﬁdence interval (CI) for the incidence rate per 100,000
per year was (1.1, 1.6) and the female 95% CI was (0.7,
1.0). By this measure, any county with a zero occurrence
had a statistically signiﬁcant low bone cancer incidence.
A zero occurrence resulted in a zero estimate for the county
standard error that reduced the 95% CI for the difference
between the county and the overall state rate to that of the
95% CI for just the state rate.
There were 31 counties with zero occurrences for males
and 50 counties with zero occurrences for females. Thus,
81 (46.6%) of the 174 comparisons were considered as
signiﬁcantly low by the 95% standard normal test of sig-
niﬁcance. None of the counties had signiﬁcantly elevated
rates. (Another 59 counties had one or two occurrences, all
of them not statistically different than the overall state
rate). The results for the 99% standard normal and the 90%
Bonferroni signiﬁcance tests were identical to the 95%
standard normal test; 81 (46.6%) were signiﬁcantly low,
and none were signiﬁcantly elevated.
unusually low
not unusual
unusually high
Fig. 4 Age-adjusted female all-cancer incidence compared to overall state female age-adjusted rate by county (1988–2007). Signiﬁcance
determined by Wilcoxon’s signed rank test (WSRT) procedure described in text
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cancer map. Maps (for males and females separately)
portraying almost half of the state’s counties as having
signiﬁcantly low rates of bone cancer could be created.
Alternatively, a decision could be made that, except for a
small number of larger counties, the rates were too unstable
to warrant mapping cancer rates by county.
Both of these approaches would be problematic. The
ﬁrst set of maps would create a misrepresentation of sig-
niﬁcance. The second approach would not take advantage
of the county-speciﬁc data on cancer incidence and the
composite information available from these observations.
The WSRT procedure identiﬁed none of the county bone
cancer incidence rates as unusually low or unusually high.
Utilizing all the data on bone cancer incidence, there was
no evidence of an unusual rate of this cancer for the period
2003–2007 in any of the counties. Two maps could be
created that would provide the impression that there were
no unusual occurrences of male or female bone cancer
incidence for the period 2003–2007 in any of the counties.
This would be the most appropriate representation of
the MCSS data and the one supported by the WSRT
procedure.
Sensitivity
Sensitivity for detecting unusual occurrences of cancer,
especially for childhood cancers, is important. In Table 4,
there are three occurrences that were statistically elevated
based on the 95% standard normal signiﬁcance test, but
significantly low
non significant
significantly high
Fig. 5 Age-adjusted male colon/rectum cancer incidence compared to overall state male age-adjusted rate by county (1988–2007). Signiﬁcance
determined by 95% standard normal conﬁdence interval for difference in the two rates
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occurred in Stearns County (a large county located just
northwest of the Minneapolis—St. Paul area). The three
occurrences were due to the high childhood female acute
lymphoblastic leukemia (ALL) rates. The high rate of
childhood female ALL increased both the categories of ‘‘all
leukemia’’ and ‘‘all cancer’’ rates for females to bring the
total elevated to 3.
The ALL data for Stearns County were examined by age
groups (0–4, 5–9, and 10–14) to evaluate the consistency of
this elevated rate. None of the rates for males were sta-
tistically signiﬁcant based on the 95% standard normal test.
unusually low
not unusual
unusually high
Fig. 6 Age-adjusted male colon/rectum cancer incidence compared to overall state male age-adjusted rate by county (1988–2007). Signiﬁcance
determined by Wilcoxon’s signed rank test (WSRT) procedure described in text
Table 3 Number (%) of statistically signiﬁcant county rates for four tests of signiﬁcance—32 cancers, 87 counties, and 2 sexes
Standard normal (95%) Standard normal (99%) Bonferroni (90%) WSRT
a (95%)
Low High Low High Low High Low High
1,256 (24.5) 85 (1.7) 1,094 (21.3) 27 (0.5) 943 (18.4) 7 (0.1) 82 (1.6) 38 (0.7)
Total comparisons = 5,133. Biologically inconsistent cancer and gender combinations excluded
MCSS 2003–2007 [All ages (n = 121,908 total cancers)]
a Wilcoxon’s signed rank test—see text
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state rate. For the period 1998–2002, the difference reached
statistical signiﬁcance: 12.2 per 100,000 per year vs. 2.8
per 100,000 for the entire state. The importance of an
observation of elevated ALL in young females in Stearns
County without a corresponding elevation in young males
is hard to interpret. Nonetheless, from a public health
surveillance perspective of identifying unusual occurrences
of cancer through disease mapping, the Stearns County
observation was an example of decreased sensitivity for the
WSRT procedure. This was the only such example iden-
tiﬁed during the evaluation of the WSRT procedure.
Discussion
There have been several methods developed to account for
the loss of speciﬁcity due to multiple statistical compari-
sons [33]. Conventional approaches, such as the Bonferroni
test of signiﬁcance, are generally viewed as inappropriate
in epidemiology as they diminish the ability to identify
meaningful differences [26, 34, 35]. In the case of cancer
mapping, there needs to be a middle ground due to the
inﬂuence that it can have on public policy. Mapping of
state cancer rates by county involves a large number of
implied comparisons, and one of the goals of mapping
these rates is the identiﬁcation of unusual cancer occur-
rences that, when found, may have important public policy
implications [15, 16, 36–38]. A recently established federal
program, Environmental Public Health Tracking [39], is
attempting to advance disease mapping and environmental
correlations. A stated goal of this program is to recognize
disease clusters in order to ‘‘understand the possible asso-
ciations between the environment and the adverse health
effects.’’
This application of the WSRT procedure is another
approach for assessing the signiﬁcance of the difference
between directly age-adjusted county cancer rates and the
overall state age-adjusted rate. Traditional presentation of
the pattern of county cancer rates occurs in several ways.
Two of the most common are to portray the county rates as
above or below the state average and to distribute the
county rates by quartiles. These approaches have become a
standard of practice [40]. The WSRT procedure does not
replace these methods. The WSRT procedure is comple-
mentary to them, serving the objective of identifying
meaningful signiﬁcant differences between county and
overall state rates without a major loss of sensitivity.
The large amount of random variation associated with
the analyses of rates based on a small number of cancers
raises concern over the precision of the estimates [41].
Several strategies are employed to address this problem.
Indirect standardization as an age-adjustment method has
been recommended for small counties where the age-spe-
ciﬁc rates are often quite variable and unreliable [42].
While this approach is useful in comparing a single county
to the overall statewide rate, the results of indirect stan-
dardization may not be as useful when comparing multiple
counties if there are large differences in the age structures
of the populations. The indirectly standardized rate is
weighted to the speciﬁc age distribution of the population
of interest [43]. Since mapping county cancer rates results
in comparisons among the counties, indirectly age-adjust-
ing cancer rates are not recommended as a method for
creating state cancer (and other rate) maps [44].
The most common strategy to address the small number
problem is to suppress analyses that are based on a number
of occurrences judged to be too low to yield valid results.
This number is not consistently deﬁned. The Kentucky
Cancer Registry uses 15 [45] and the National Center for
Health Statistics recommends 25 as the minimum [46]. The
National Program of Cancer Registries does not provide
rates if the cell size is smaller than 16 or the population
smaller than 50,000 people [47]. Important results from
identifying and studying populations with low cancer
incidence are well documented [48, 49]. Suppressing
analyses of low cancer rates solely on the basis that they
represent numbers that are considered too low to publish
may result in missing useful insights [31]. Mapping
important differences between low county cancer rates
compared to the overall state rate can be facilitated by the
WSRT procedure due to its decreased sensitivity to low
rate instability.
The evaluation of the performance of the WSRT pro-
cedure was empirical and based on cancer incidence data
from Minnesota. Population-based cancer incidence data in
the United States are collected under similar protocols [50],
and it is likely that the WSRT procedure would perform
Table 4 Number (%) of statistically signiﬁcant county rates for four tests of signiﬁcance—32 cancers, 87 counties, and 2 sexes
Standard normal (95%) Standard normal (99%) Bonferroni (90%) WSRT
a (95%)
Low High Low High Low High Low High
1,990 (38.8) 3 (0.01) 1,813 (35.3) 0 (0.0) 1,728 (33.7) 0 (0.0) 9 (0.2) 0 (0.0)
Total comparisons = 5,133. Biologically inconsistent cancer and gender combinations excluded
MCSS 1988–2007 [Ages 0–14 (n = 3,188 total cancers)]
a Wilcoxon’s signed rank test—see text
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ther the performance of the WSRT procedure found in this
evaluation can be generalized for other applications and for
use in all states requires further investigation.
The computational algorithm for the WSRT procedure
used in this evaluation was coded in FORTRAN—a
mathematically based programing language. The transla-
tion of this extension of the Wilcoxon’s signed rank test
into an executable algorithm was straightforward and can
be incorporated as a FORTRAN (available from the ﬁrst
author upon request) or C subroutine, or it can be created
within a SAS program. The simplicity of coding required
for calculating the WSRT signiﬁcance is an appealing
attribute of this procedure.
Asthenumberofobservationsincrease,theprecisionofthe
estimates increase, often resulting in small differences
becoming statistically signiﬁcant. The WSRT procedure was
notasgreatlyimpactedbythelargenumbereffectbutitisnot
immune to it. Identiﬁcation and interpretation of important
differences in cancer rates will always require skill and
judgment.TheWSRTprocedureisanallyinthisprocessasit
reduces the number of cancer rates that need to be evaluated.
As illustrated throughout the evaluation of the WSRT pro-
cedure, the level of signiﬁcance for differences in directly age-
standardized rates, such as 0.05 or 0.01 is theoretical; each
application will likely yield a computed signiﬁcance that is
different than the desired theoretical level of signiﬁcance. For
the purposes of cancer mapping, it is not the level of signiﬁ-
cance that is important, but the fact that the signiﬁcantly dif-
ferent rates represent truly unusual occurrences. John Tukey
recommended that for diseasemapping, signiﬁcantdifferences
be described as ‘‘unusual occurrences.’’ The WSRT procedure
provides a useful method to portray the differences in directly
age-adjusted cancer rates occurring at the county level com-
pared to the overall state rate as ‘‘unusually low,’’ ‘‘not unu-
sual,’’ or ‘‘unusually high.’’
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Appendix 1
Example calculations for the nonparametric procedure
(WSRT)
Consider the data in Table 5 which contains age-stan-
dardized male cancer rates for all cancers combined for
twenty counties and the entire state (per 100,000 per year).
These data are from the MCSS for the period 1988–2007.
The standard error for each of the counties (sei) and the
state (se) is also provided in Table 5. The twenty counties
were a sample (small, medium, and large) of all 87 Min-
nesota counties used to illustrate the WSRT procedure. The
steps are identical to those described in the text.
Step 1 Create the 20, 95% standard normal conﬁdence
intervals (CILi, CIUi) for the difference between the county
rate and the state rate (diffi) from the formula: diffi ± 1.96
ðse2
i þ se2Þ
1=2. For example, Aitkin County: diff1 =
546.56 - 555.62 =- 9.06; ðse2
1 þ se2Þ
1=2 ¼ð 259:21 þ
1:3924Þ
1=2 ¼ 16:14:
The (CIL1, CIU1)i s-9.06 ± 31.64 = (-40.70, 22.58).
The diffi and their corresponding (CILi, CIUi) for all
twenty counties are given in Table 6. Note that there are 11
occurrences that fall outside their respective 95% standard
normal conﬁdence intervals, that is, the conﬁdence interval
for the difference does not contain zero.
Step 2 For twenty counties, m = 20 and M =
m(m ? 1)/2 = 210. From the 210 Walsh averages for the
upper and lower conﬁdence limits. For example, for i = 1
and j = 2, Wk
L ¼ð CILi þ CILjÞ=2 ¼ð   40:70 þ 15:01Þ=
2 ¼  12:84 (rounded to two decimal places) and
Wk
U ¼ð CILi þ CILjÞ=2 ¼ð 22:58 þ 40:95Þ=2 ¼ 31:76.
Table 5 Age-standardized rates and their standard errors for males,
all cancers combined
County/region Standardized rate Standard error
Entire State 555.62 1.18
Aitkin 546.56 16.10
Anoka 583.60 6.51
Becker 585.57 13.48
Beltrami 569.83 13.55
Big Stone 598.71 27.58
Blue Earth 528.55 11.07
Cass 566.25 13.16
Faribault 534.10 16.23
Fillmore 526.72 14.54
Goodhue 520.73 10.99
Kittson 466.45 25.96
Le Sueur 524.68 14.53
Lincoln 483.79 23.02
McLeod 546.21 13.11
Olmsted 628.29 8.34
Scott 564.36 11.58
St. Louis 554.88 5.21
Washington 541.64 7.27
Wright 553.24 9.72
Yellow medicine 516.53 19.23
MCSS 1988–2007
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Walsh lower limit averages (Table 7) and Walsh upper
limit averages (Table 8).
Step 3 Rank the lower and upper 210 Walsh averages in
numeric order.
Step 4 Calculate Ca ¼
mðmþ1Þ
4   Zða=2Þ
mðmþ1Þð2mþ1Þ
24
hi 1=2
.
For m = 20 and Z(a/2) = 1.96, Ca = 52, rounded to the
nearest integer and M ? 1 - Ca = 159; M = 210.
Step 5 The joint conﬁdence interval is W52
L ; W159
U
  
.
The 52nd ordered Walsh average is -55.45 and the 159th
ordered Walsh average is 35.27. Thus, (-55.45, 35.27) is
the joint conﬁdence interval for the diffi when zero lies
outside the (CILi, CIUi), i = 1, 20.
Steps 6a and b Compare each (CILi, CIUi) in Table 6 to
zero. If the (CILi, CIUi) contains zero, the difference is
considered nonsigniﬁcant. For Aitkin County, this interval
contains zero. No further evaluation is required and com-
parison to the WSRT conﬁdence interval, W52
L ; W159
U
  
,
is not needed. The WSRT evaluation of the statistical
signiﬁcance of the difference is also taken as not unusual.
For Anoka County, the difference in age-standardized
rates was 27.98. The corresponding (CILi, CIUi) does not
contain zero, and comparison of the Anoka County/State
difference in rates to the WSRT conﬁdence interval is
appropriate. Since 27.98 is contained in the interval
(-55.45, 35.27), the WSRT evaluation of signiﬁcance is
that the Anoka County rate was not unusual.
For Olmsted County (Rochester), diffi = 72.67 and the
95% standard normal conﬁdence interval, (56.16, 89.18),
does not contain zero. This difference is also larger than the
upper limit of (-55.45, 35.27) and the WSRT signiﬁcance
test indicates an elevated (unusually high) rate for Olmsted
County.
Table 9 contains a summary of the 95% standard
normal level of signiﬁcance and the signiﬁcance deter-
mined by the WSRT procedure. Eleven (8 low, 3 high)
of the county rates were statistically different than the
state rate as zero lies outside their respective 95%
standard normal conﬁdence intervals (Table 6). Only
three (2 low, 1 high) were statistically unusual based on
the WSRT procedure. This reduction in the number of
signiﬁcant differences is a salient feature of the WSRT
procedure.
Table 6 Differences between county and state rate (diffi), lower and
upper 95% standard normal conﬁdence limits (CL), and signiﬁcance
(Sig)
County diffi Lower CL Upper CL Sig
Aitkin -9.06 -40.70 22.58 2
Anoka 27.98 15.01 40.95 3
Becker 29.95 3.43 56.47 3
Beltrami 14.21 -12.45 40.87 2
Big Stone 43.09 -11.02 97.20 2
Blue Earth -27.07 -48.89 -5.25 1
Cass 10.63 -15.27 36.53 2
Faribault -21.52 -53.41 10.37 2
Fillmore -28.90 -57.49 -0.31 1
Goodhue -34.89 -56.55 -13.23 1
Kittson -89.17 -140.10 -38.24 1
Le Sueur -30.94 -59.51 -2.37 1
Lincoln -71.83 -117.01 -26.65 1
McLeod -9.41 -35.21 16.39 2
Olmsted 72.67 56.16 89.18 3
Scott -10.74 -21.21 -0.27 1
St. Louis 8.74 -14.07 31.55 2
Washington -13.98 -28.42 0.46 2
Wright -2.38 -21.57 16.81 2
Yellow medicine -39.09 -76.85 -1.33 1
1 low, 2 not signiﬁcant, 3 high
Table 7 Walsh lower
conﬁdence limits averages
(M = 210)
First 42 of the 210 Walsh lower
limit averages
-40.70 -12.84 -18.64 -26.57 -25.86 -44.80 -27.98
-47.06 -49.10 -48.63 -90.40 -50.11 -78.85 -37.96
7.73 -27.39 -30.96 -34.56 -31.14 -58.78 15.01
9.22 1.28 2.00 -16.94 -0.13 -19.20 -21.24
-20.77 -62.55 -22.25 -51.00 -10.10 35.59 0.47
-3.10 -6.70 -3.28 -30.92 3.43 -4.51 -3.79
Table 8 Walsh upper
conﬁdence limits averages
(M = 210)
First 42 of the 210 Walsh upper
limit averages
22.58 31.76 39.53 31.72 59.89 8.67 29.55
16.48 11.14 4.68 -7.83 10.11 -2.04 19.49
55.88 27.07 11.16 11.52 19.70 10.63 40.95
48.71 40.91 69.07 17.85 38.74 25.66 20.32
13.86 1.36 19.29 7.15 28.67 65.06 36.25
20.34 20.70 28.88 19.81 56.47 48.67 76.83
Cancer Causes Control (2012) 23:791–805 803
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